12-o-tetradecanoylphorbol-13-acetate reduces activation of hepatic stellate cells by inhibiting the hippo pathway transcriptional coactivator yap

HIGHLIGHTS

  • who: Chang Wan Kim and colleagues from the Department of Thoracic and Cardiovascular Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea have published the Article: 12-O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP, in the Journal: Cells 2023, 91 of /2023/
  • what: As the quantity of activated HSCs is known to correlate with fibrosis severity , controlling the activity of HSCs is considered essential for the treatment of liver fibrosis. Through comprehensive analysis, the authors aimed to evaluate whether the induction of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?